Our results suggest that NGAL and NGAL-R, overexpressed in untreated CLL, participate in the deregulation of the apoptotic machinery in CLL cells, and may be potential therapeutic clues for CLL treatment. This evidence concerns the gene LCN2 and B-cell chronic lymphocytic leukemia.